98%
921
2 minutes
20
Mucocutaneous leishmaniasis, which mostly occurs in the New World, is mainly associated with Leishmania braziliensis and to a lesser degree L. panamensis and L. amazonensis infections. Primary mucosal leishmaniasis is very rare in Iran in spite of high prevalence of cutaneous and visceral leishmanisis. A nine-year-old boy had cutaneous leishmaniaisis for five years involving the left side of his face; he then developed swelling and ulceration of the lip and left side buccal mucosa five months before hospital admission. He had severe swelling of the lower lip and there was ulceration and bleeding of the buccal mucosa. Direct smear revealed leishman bodies and nested PCR confirmed the presence of kinetoplast DNA of L. major in the oral mucosal specimen. The patient received amphotericin B deoxycholate 1 mg/kg/day for one month. The lip and face inflammatory reaction disappeared to nearly normal after one month of therapy. The patient was discharged with ketoconazole (5mg/kg/day) for six weeks. To our knowledge, this is the first report of mucocutaneous leishmaniasis caused by L. major in Iran.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.3855/jidc.2754 | DOI Listing |
Case Rep Dent
August 2025
Department of Medicine and Surgery, University of Parma, Parma, Italy.
The primary objective of the present study is the retrospective analysis of a clinical case of oral leishmaniasis treated at Parma Hospital and a review of the literature on mucosal leishmaniasis (ML) with oral cavity involvement. We report the case of a patient diagnosed in 2017 with mucocutaneous leishmaniasis who was referred to our clinic due to the emergence of oral manifestations. Through a detailed review of the clinical documentation, we aim to describe the clinical presentation, diagnosis, treatment choices made, and evolution of the disease.
View Article and Find Full Text PDFPLoS Negl Trop Dis
August 2025
Dermatovenerology Department, College of Medicine and Health Sciences, Bahir Dar University, Bahir Dar, Ethiopia.
Background: Cutaneous leishmaniasis (CL) is clinically classified into localized (LCL), mucocutaneous (MCL) and diffuse (DCL) types. While conducting a treatment study on CL at two sites in Ethiopia (Boru Meda and Gondar), differences in opinion in the classification of CL became apparent. The lack of uniformly understandable classifications has made comparison and generalizability of research findings challenging.
View Article and Find Full Text PDFFront Immunol
August 2025
Instituto de Microbiologia Paulo de Góes - Universidade Federal do Rio de Janeiro, Rio de Janeiro, Rio de Janeiro, Brazil.
Mucosal Leishmaniasis is one of the most aggressive clinical manifestations of infection disease, characterized by the destruction of nasal and oral tissues. The mechanisms by which this disease occurs are still not well understood due to the lack of effective experimental models. Mucosal leishmaniasis is associated with inflammatory response, especially Th17 response.
View Article and Find Full Text PDFBMC Infect Dis
August 2025
Basic Sciences in Infectious Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Background: While numerous studies have investigated the role and presence of RNA viruses within Leishmania parasites, the existing literature presents a fragmented view of Leishmania RNA virus (LRV) prevalence in parasites associated with cutaneous leishmaniasis (CL). Therefore, the present study aimed to elucidate the prevalence of LRV in parasites obtained from patients with CL.
Methods: To achieve this aim, we conducted a systematic literature search across international databases, specifically Web of Science, PubMed, Embase, and Scopus.
J Microsc
July 2025
Department of Genetics and Biochemistry, Clemson University, Clemson, South Carolina, USA.
Kinetoplastid parasites include several species. Trypanosoma brucei causes African sleeping sickness in humans and a wasting disease nagana in livestock. Trypanosoma cruzi is the causative agent of Chagas disease and Leishmania species cause leishmaniasis, which can present with visceral, cutaneous, or mucocutaneous symptoms.
View Article and Find Full Text PDF